Follow-The-Filings

Security · featured owners

LH Labcorp Holdings Inc.

Health Care COM SHS Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 1.9%
  • $130M
  • 2 reduce 1 exit

LH (Labcorp Holdings Inc.) is held in 3 featured 13F books as of 2026 Q2. Wallace Weitz - Weitz Investment Management is the largest tracked holder by portfolio weight (1.9%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.9% (Wallace Weitz - Weitz Investment Management) · not free-float ownership

  1. Wallace Weitz 1.9%
  2. John Rogers reduce 0.97%
  3. Jensen Investment Management reduce 0.11%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
John Rogers - Ariel Investments 2026 Q2 0.97% Reduce −1.4% 349,112 $98M history
Wallace Weitz - Weitz Investment Management 2026 Q2 1.9% Hold 99,050 $28M history
Jensen Investment Management 2026 Q2 0.11% Reduce −13.1% 16,050 $4M history
Lee Ainslie - Maverick Capital exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 1,596 $426K history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 16 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 · 4 forms Filing Doc
4 Period Aug 17, 2026 Filing Doc
4 Period Aug 11, 2026 Filing Doc
4 Period Aug 4, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 1, 2026 · 2 forms Filing Doc
4 Period Jun 8, 2026 Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period Mar 26, 2026 · 12 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $12.16B $13.01B $13.95B
Gross profit $3.36B $3.62B $4.01B
Gross margin * 27.7% 27.9% 28.8%
Net income $418M $746M $876.5M
Net margin * 3.4% 5.7% 6.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.77B $4.81B $4.02B
Total non-current assets * $12.96B $13.57B $14.37B
Total assets $16.73B $18.38B $18.39B
Total current liabilities $3.23B $3.33B $2.82B
Total non-current liabilities * $5.61B $6.98B $6.93B
Total equity $7.88B $8.05B $8.62B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.33B $1.59B $1.64B
Cash from investing -$1.17B -$1.37B -$1.19B
Cash from financing -$0.059B $0.78B -$1.46B
Net change in cash $106.8M $981.9M -$986.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders